Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension
- 1 April 2001
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 17 (4) , 647-652
- https://doi.org/10.1183/09031936.01.17406470
Abstract
There are no reliable predictors of mortality in primary pulmonary hypertension (PPH). This study assessed whether exercise oxygen desaturation and distance achieved during a six-minute walk are associated with mortality in moderately symptomatic patients with PPH.Thirty-four patients with PPH underwent a pretreatment six-minute walk test, and an invasive haemodynamic assessment of pulmonary vasodilator reserve, to select the best treatment option (epoprostenol in 27 and nifedipine in 7). Median follow-up was 26 months (12 months for the nonsurvivors was 26%), and median survival, >46 months by Kaplan-Maier estimate.The mean±sd distance walked was 275±155 m and reduction in arterial oxygen saturation (Sa,O2) at maximal distance (ΔSa,O2) was 8.4±4.5%. A distance ≤300 m increased mortality risk by 2.4, and a ΔSa,O2of ≥10 % increased mortality risk by 2.9. OnlySa,O2at peak distance, ΔSa,O2and pulmonary vascular resistance (PVR) were related to mortality. After adjusting for PVR, there remained a 27% increase in risk of death for each per cent decrease inSa,O2.The six-minute walk distance and exercise oxygen saturation may be helpful in selecting patients with primary pulmonary hypertension for whom transplant listing is appropriate.Keywords
This publication has 19 references indexed in Scilit:
- Inhaled nitric oxide in primary pulmonary hypertensionJournal of the American College of Cardiology, 1998
- Six-Minute Walk TestingSeminars in Respiratory and Critical Care Medicine, 1998
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- Effect of Hemoglobin on the Oxygen Uptake of Patients With Coronary Artery DiseaseJournal of Cardiopulmonary Rehabilitation, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Pulmonary-Function TestingNew England Journal of Medicine, 1994
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Comparison of the effects of adenosine and nifedipine in pulmonary hypertensionJournal of the American College of Cardiology, 1992
- High dose titration of calcium channel blocking agents for primary pulmonary hypertension: Guidelines for short-term drug testingJournal of the American College of Cardiology, 1991
- How should we measure function in patients with chronic heart and lung disease?Journal of Chronic Diseases, 1985